0.9000
13-二月-25 16:45:00
15 分钟延时
股票
+0.0101
+1.13%
今日范围
0.8700 - 0.9150
ISIN
N/A
来源
NASDAQ
IMUNON Announces First Patient enrolled in Phase 1/2 Clinical Trial of IMNN-001 in Combination with bevacizumab in Advanced Ovarian Cancer
18 10月 2023 08:30:00 条件 Nasdaq GlobeNewswire
IMUNON Appoints Dr. Patrick Ott to its Scientific Advisory Board
06 10月 2023 08:30:00 条件 Nasdaq GlobeNewswire